ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003

Three CBCCPs Say They’ll Appeal To NC On Termination

March 21, 1980

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011